Cargando…

Placebo response in treatment resistant depression: a systematic review and meta-analysis of multiple treatment modalities

AIMS: The placebo response in depression clinical trials is a major contributing factor for failure to establish the efficacy of novel and repurposed treatments. However, it is not clear as to what the placebo response in treatment-resistant depression (TRD) patients is or whether it differs across...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jones, Brett D M, Weissman, Cory R., Karbi, Jewel, Vine, Tya, Mulsant, Louise S., Mulsant, Benoit, Brunoni, Andre, Husain, M. Ishrat, Razza, Lais B., Blumberger, Daniel, Daskalakis, Zafiris J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771424/ http://dx.doi.org/10.1192/bjo.2021.697

Ejemplares similares

Magnitude of the Placebo Response Across Treatment Modalities Used for Treatment-Resistant Depression in Adults: A Systematic Review and Meta-analysis
por: Jones, Brett D. M., et al.
Publicado: (2021)

Protocol for a systematic review and meta-analysis of the placebo response in treatment-resistant depression: comparison of multiple treatment modalities
por: Jones, Brett D M, et al.
Publicado: (2021)

Predictors of change in suicidal ideation across treatment phases of major depressive disorder: analysis of the STAR*D data
por: Weissman, Cory R., et al.
Publicado: (2021)

Inflammation as a treatment target in mood disorders: review
por: Jones, Brett D. M., et al.
Publicado: (2020)

Magnetic Seizure Therapy for Suicidality in Treatment-Resistant Depression
por: Weissman, Cory R., et al.
Publicado: (2020)

COVID-19: Implications for bipolar disorder clinical care and research
por: Xue, Siqi, et al.
Publicado: (2020)

Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)
por: Husain, Muhammad Ishrat, et al.
Publicado: (2020)

Targeting Metabolic Dysfunction for the Treatment of Mood Disorders: Review of the Evidence
por: Jones, Brett D. M., et al.
Publicado: (2021)

Magnetic seizure therapy reduces suicidal ideation and produces neuroplasticity in treatment-resistant depression
por: Sun, Yinming, et al.
Publicado: (2018)

The Impact of COVID-19 on Psychiatric Emergency and Inpatient Services in the First Month of the Pandemic in a Large Urban Mental Health Hospital in Ontario, Canada
por: Kim, Helena K., et al.
Publicado: (2021)

Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial
por: Husain, Muhammad Ishrat, et al.
Publicado: (2023)

Brief App-Based Cognitive Behavioral Therapy for Anxiety Symptoms in Psychiatric Inpatients: Feasibility Randomized Controlled Trial
por: Sharma, Gaurav, et al.
Publicado: (2022)

Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?
por: Husain, Muhammad Ishrat, et al.
Publicado: (2023)

Predictors of adherence to electronic self-monitoring in patients with bipolar disorder: a contactless study using Growth Mixture Models
por: Ortiz, Abigail, et al.
Publicado: (2023)

Management of Treatment-Resistant Depression: Challenges and Strategies
por: Voineskos, Daphne, et al.
Publicado: (2020)

A cross-sectional study of cognitive performance in bipolar disorder across the lifespan: the cog-BD project
por: Jones, Brett D. M., et al.
Publicado: (2023)

Cortical inhibition, facilitation and plasticity in late-life depression: effects of venlafaxine pharmacotherapy
por: Lissemore, Jennifer I., et al.
Publicado: (2021)

Recruiting for a randomized clinical trial for late-life depression during COVID-19: outcomes of provider referrals vs. Facebook self-referrals
por: Ainsworth, Nicholas, et al.
Publicado: (2023)

Protocol for a systematic review and meta-analysis of coordinate-based network mapping of brain structure in bipolar disorder across the lifespan
por: Jones, Brett D. M., et al.
Publicado: (2023)

Boxing as an Intervention in Mental Health: A Scoping Review
por: Bozdarov, Johny, et al.
Publicado: (2022)

Repetitive Transcranial Magnetic Stimulation to Maintain Treatment Response to Electroconvulsive Therapy in Depression: A Case Series
por: Noda, Yoshihiro, et al.
Publicado: (2013)

Predictors of adherence to electronic self-monitoring in patients with bipolar disorder: a contactless study using Growth Mixture Models
por: Ortiz, A., et al.
Publicado: (2023)

Theta-Gamma Coupling and Working Memory in Alzheimer’s Dementia and Mild Cognitive Impairment
por: Goodman, Michelle S., et al.
Publicado: (2018)

A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocol
por: Husain, M. I., et al.
Publicado: (2023)

Suicidal Ideation and Obsessive-Compulsive Disorder: Links and Knowledge
por: Benster, Lindsay L, et al.
Publicado: (2022)

Exploratory genome-wide analyses of cortical inhibition, facilitation, and plasticity in late-life depression
por: Wathra, Rafae A., et al.
Publicado: (2023)

Psychotherapy Training in a Competency-Based Medical Education Psychiatry Residency: A Proposal for a Practical and Socially Responsible Model
por: Fefergrad, Mark, et al.
Publicado: (2021)

Selective modulation of brain network dynamics by seizure therapy in treatment-resistant depression
por: Atluri, Sravya, et al.
Publicado: (2018)

Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression: The FOUR-D Randomized Noninferiority Clinical Trial
por: Blumberger, Daniel M., et al.
Publicado: (2022)

Baseline markers of cortical excitation and inhibition predict response to theta burst stimulation treatment for youth depression
por: Dhami, Prabhjot, et al.
Publicado: (2023)

Association of Molecular Senescence Markers in Late-Life Depression With Clinical Characteristics and Treatment Outcome
por: Diniz, Breno S., et al.
Publicado: (2022)

Experiences with legally mandated treatment in patients with schizophrenia: A systematic review of qualitative studies
por: Plahouras, Joanne E., et al.
Publicado: (2020)

Low-Dose Augmentation With Buprenorphine for Treatment-Resistant Depression: A Multisite Randomized Controlled Trial With Multimodal Assessment of Target Engagement
por: Lee, Hyewon H., et al.
Publicado: (2021)

Low-dose augmentation with buprenorphine increases emotional reactivity but not reward activity in treatment resistant mid- and late-life depression
por: Lin, Chemin, et al.
Publicado: (2019)

A Randomized Double-Blind Sham-Controlled Study of Transcranial Direct Current Stimulation for Treatment-Resistant Major Depression
por: Blumberger, Daniel M., et al.
Publicado: (2012)

Neurophysiological Biomarkers in Schizophrenia—P50, Mismatch Negativity, and TMS-EMG and TMS-EEG
por: Kim, Helena K., et al.
Publicado: (2020)

Melatonin use during pregnancy and lactation: A scoping review of human studies
por: Vine, Tya, et al.
Publicado: (2021)

Recruiting for a Randomized Clinical Trial for Late-Life Depression During COVID-19: Outcomes of Provider Referrals Versus Facebook Self-Referrals
por: Ainsworth, Nicholas J., et al.
Publicado: (2023)

The Insula: A Brain Stimulation Target for the Treatment of Addiction
por: Ibrahim, Christine, et al.
Publicado: (2019)

Effect of Adjunctive Simvastatin on Depressive Symptoms Among Adults With Treatment-Resistant Depression: A Randomized Clinical Trial
por: Husain, M. Ishrat, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vgk452hutuv8ojg1ucl5c3tflv